Renalytix Plc (LON:RENX – Get Free Report) fell 4.6% on Tuesday . The company traded as low as GBX 30 ($0.37) and last traded at GBX 31 ($0.39). 34,497 shares traded hands during trading, a decline of 94% from the average session volume of 618,802 shares. The stock had previously closed at GBX 32.50 ($0.40).
Renalytix Stock Down 4.6 %
The firm’s fifty day moving average is GBX 32.04 and its two-hundred day moving average is GBX 28.22. The firm has a market cap of £37.18 million, a price-to-earnings ratio of -86.11 and a beta of 1.92. The company has a debt-to-equity ratio of 173.95, a current ratio of 0.59 and a quick ratio of 2.42.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Featured Stories
- Five stocks we like better than Renalytix
- Trading Stocks: RSI and Why it’s Useful
- Silicon Motion Proves That AI in Motion Stays in Motion
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Undervalued UnitedHealth Group Won’t Be For Long
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
